{"id":"W4416409531","doi":"10.3390/curroncol32110648","title":"Zolbetuximab or Immunotherapy as the Initial Targeted Therapy in CLDN18.2-Positive, HER2-Negative Advanced Gastric Cancer: Weighing the Options","year":2025,"lang":"en","type":"article","venue":"Current Oncology","topic":"Barrier Structure and Function Studies","field":"Neuroscience","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of British Columbia; BC Cancer Agency; University of Alberta","funders":"Astellas Pharma","keywords":"Immunotherapy; Targeted therapy; Biomarker; Cancer; Nausea; Chemotherapy; Vomiting; Clinical trial","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":true,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000220365,0.0002403365,0.0003340332,0.0001583187,0.0008091153,0.00005207006,0.0004661934,0.00009021833,0.0002502755],"category_scores_gemma":[0.0003873789,0.0001255552,0.00009924258,0.001257667,0.0005468116,0.0001454404,0.0001176925,0.0007074042,0.00001575757],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002467185,"about_ca_system_score_gemma":0.0004456974,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001382651,"about_ca_topic_score_gemma":0.0003408841,"domain_scores_codex":[0.9978802,0.0007383145,0.0003582021,0.0004394689,0.0001847895,0.0003989931],"domain_scores_gemma":[0.9977367,0.001656197,0.0001753837,0.0002925227,0.0001061664,0.00003302563],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.002521493,0.0004286551,0.001675113,0.00001067975,0.0001072619,0.00001770571,0.007190576,0.0001735233,0.01228419,0.008382783,0.003141208,0.9640668],"study_design_scores_gemma":[0.008965073,0.001473026,0.04791902,0.0001310934,0.00005638483,0.00004000396,0.003733783,0.0002846882,0.03340258,0.008089046,0.8954299,0.0004753843],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8946573,0.0230215,0.002644426,0.03549027,0.02345476,0.00372305,0.0001995888,0.0002709054,0.01653819],"genre_scores_gemma":[0.97565,0.01737203,0.00008221618,0.005373826,0.0002851516,0.0008142886,0.00000404286,0.00001855029,0.0003999042],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.9635914,"threshold_uncertainty_score":0.6223143,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07933901791497011,"score_gpt":0.4185734319141357,"score_spread":0.3392344139991656,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}